tradingkey.logo
tradingkey.logo
Search

Dermata Therapeutics Inc

DRMA
Add to Watchlist
0.621USD
-0.040-6.05%
Close 11-13 16:00(ET)
3.08MMarket Cap
LossP/E TTM

DRMA Financials

See Dermata Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
3.08M
Dividend TTM
0.00
P/E TTM
-0.15
EPS TTM
-4.17
Revenue
--
Net Profit
-12.29M
ROE
-103.58%
ROA
-81.31%
Dermata Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.74/-0.55
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
66.57%-0.55
95.55%-0.74
89.29%-0.48
92.01%-1.65
91.92%-1.65
60.37%-16.57
93.67%-4.47
69.15%-20.60
74.76%-20.41
55.68%-41.82
79.29%-70.58
79.44%-66.78
---80.86
---94.35
---340.85
---324.84
----
----
----
----
Net Profit
-66.75%-2.82M
-74.42%-2.97M
19.79%-1.85M
40.91%-1.86M
46.68%-1.69M
39.87%-1.70M
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
67.36%-1.67M
43.29%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-1190.67%-5.12M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Operating profit
-62.35%-2.86M
-70.00%-3.01M
17.67%-1.93M
40.62%-1.90M
45.42%-1.76M
38.53%-1.77M
26.96%-2.34M
-44.17%-3.20M
-78.02%-3.23M
-66.46%-2.88M
-40.65%-3.20M
-29.69%-2.22M
25.92%-1.81M
36.55%-1.73M
18.25%-2.28M
32.95%-1.71M
-42.86%-2.45M
-105.31%-2.73M
-23.18%-2.79M
-419.48%-2.55M
Net Profit
-66.75%-2.82M
-74.42%-2.97M
19.79%-1.85M
40.91%-1.86M
46.68%-1.69M
39.87%-1.70M
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
67.36%-1.67M
43.29%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-1190.67%-5.12M
Current assets
26.81%6.43M
-22.35%5.16M
-25.38%7.47M
122.53%7.86M
-24.16%5.07M
26.81%6.64M
93.16%10.01M
-55.71%3.53M
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.30M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
447.73%9.04M
--11.62M
Total current liabilities
----
78.62%1.83M
-61.07%1.05M
-16.85%1.64M
-42.90%1.11M
-46.50%1.03M
97.10%2.70M
21.51%1.97M
112.27%1.95M
180.94%1.92M
13.65%1.37M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
25.86%1.50M
-16.81%1.37M
26.87%1.19M
--1.52M
Total assets
30.84%6.64M
-19.87%5.32M
-25.38%7.47M
122.53%7.86M
-24.16%5.07M
26.81%6.64M
93.16%10.01M
-55.71%3.53M
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.30M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
447.73%9.04M
--11.62M
Total liabilities
145.62%2.73M
78.62%1.83M
-61.07%1.05M
-16.85%1.64M
-42.90%1.11M
-46.50%1.03M
97.10%2.70M
21.51%1.97M
112.27%1.95M
180.94%1.92M
13.65%1.37M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
25.86%1.50M
-16.81%1.37M
26.87%1.19M
--1.52M
Total equity
-1.37%3.91M
-37.88%3.49M
-12.17%6.41M
298.66%6.22M
-16.48%3.96M
69.20%5.61M
91.73%7.30M
-75.44%1.56M
-25.99%4.74M
-58.68%3.32M
-52.92%3.81M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.19%7.47M
2009.83%9.66M
1002.88%7.85M
--10.11M
Net operating income
-46.90%-2.65M
10.00%-2.42M
-28.21%-2.48M
54.38%-1.33M
47.24%-1.80M
-26.55%-2.69M
28.49%-1.93M
-153.95%-2.91M
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.70M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
-235.97%-2.61M
-236.57%-1.80M
Net investment
---52.98K
---110.67K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net financing
25603.16%3.31M
99.94%-323.00
-77.59%1.90M
6206.42%4.19M
-100.28%-12.99K
-123.42%-547.86K
--8.49M
-103.51%-68.57K
13131.36%4.62M
54.71%2.34M
-100.00%0.00
--1.95M
-17809.50%-35.42K
-64.64%1.51M
--4.18M
100.00%0.00
-100.00%200.00
--4.28M
-100.00%0.00
-100.20%-626.00

FAQs

What are the current assets of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its current assets were 7.86M, with a year-on-year change of 122.53.

What are the total assets of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its total assets of Dermata Therapeutics Inc were 7.86M, with a year-on-year change of 122.53.

What are the total liabilities of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its total liabilities of Dermata Therapeutics Inc were 1.64M, with a year-on-year change of -16.85.

What is the total equity of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its total equity of Dermata Therapeutics Inc was 6.22M, with a year-on-year change of 298.66.

What is the net operating income of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its net operating income of Dermata Therapeutics Inc was -7.77M, with a year-on-year change of 37.88.

What is the net financing of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its net financing of Dermata Therapeutics Inc was 12.12M, with a year-on-year change of 75.97.

What is the Earnings Per Share (EPS) of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.16, with a year-on-year change of 89.84.

What is the net income of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its net income was -7.56M, with a year-on-year change of 38.49.

What is the Return on Equity (ROE) of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -194.20, with a year-on-year change of 37.45.

What is the Return on Assets (ROA) of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -132.63, with a year-on-year change of 37.87.

What is the operating profit of Dermata Therapeutics Inc?

According to Dermata Therapeutics Inc's FY2025 earnings report, its operating profit was -7.77M, with a year-on-year change of 37.88.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.